KPV

Research Use Only Disclaimer

KPV is sold strictly for laboratory, academic and institutional research. It is not for human or animal consumption, injection, or any therapeutic, diagnostic or veterinary use. PCH Peptides does not provide dosage, administration or usage guidance.

What Is KPV?

KPV is a synthetic tripeptide composed of three amino acids: lysine (Lys), proline (Pro) and valine (Val).

Its amino acid sequence, Lys-Pro-Val, corresponds to residues 11–13 at the C-terminal end of alpha-melanocyte-stimulating hormone (alpha-MSH), a naturally occurring peptide derived from the proopiomelanocortin (POMC) precursor protein.

KPV represents one of the shortest peptide fragments associated with alpha-MSH sequence research.

Researchers investigate KPV in controlled laboratory models involving inflammatory signalling, molecular interactions, peptide transport and cellular responses.

Experimental studies have examined its interactions with pathways associated with nuclear factor kappa B (NF-κB), a transcription factor involved in inflammatory and cellular signalling processes.

The peptide’s relatively simple three-amino-acid structure also makes it relevant to biochemical investigations involving short-peptide stability, molecular characterization and transport mechanisms.

KPV is available individually or as one of the four components in KLOW Blend, a predefined research formulation containing GHK-Cu, BPC-157, TB-500 and KPV.

For additional background on peptide structures and laboratory research applications, explore the What Are Peptides? Research Guide.

KPV 10mg Specifications

KPV in Laboratory Research

KPV is investigated in biochemical and cellular studies involving short-peptide chemistry, inflammatory signalling, molecular stability and peptide transport.

Inflammatory Signalling Research

KPV is studied in non-clinical laboratory models involving cellular signalling pathways associated with inflammatory responses.

Researchers have investigated its effects on molecular processes involving NF-κB, a transcription factor associated with the regulation of inflammatory gene expression.

Experimental studies may examine changes in signalling markers and cellular responses under controlled laboratory conditions.

These findings are relevant to understanding peptide-related molecular mechanisms and do not establish therapeutic effectiveness in humans.

Alpha-MSH Fragment Research

Alpha-melanocyte-stimulating hormone is a naturally occurring peptide composed of 13 amino acid residues.

KPV corresponds to the final three residues of this sequence.

Researchers investigate KPV to characterize the molecular properties of short fragments derived from larger regulatory peptides.

Comparative studies may examine how differences in peptide length and amino acid composition influence molecular interactions and cellular signalling.

KPV’s structure differs considerably from full-length alpha-MSH, and the two should not be assumed to have identical receptor-binding characteristics.

Peptide Transport and Stability Studies

As a three-amino-acid peptide, KPV is relevant to laboratory research examining short-peptide transport, stability and molecular behaviour.

Researchers may investigate its chemical properties, degradation characteristics and interactions with experimental cellular systems.

Its compact structure makes it suitable for analytical studies involving peptide identification and characterization.

Research findings from these experimental models should not be interpreted as evidence of clinical safety or effectiveness.

Certificate of Analysis

PCH Peptides provides batch-specific analytical documentation for its KPV research material.

The PCH Peptides COA Library currently lists one Certificate of Analysis and one endotoxin report for KPV.

Researchers should review the applicable batch Certificate of Analysis to confirm the material’s identity, HPLC purity percentage and other available analytical findings.

The exact purity percentage should be taken directly from the current batch documentation rather than assumed from general product specifications.

The endotoxin report should be reviewed separately because endotoxin testing and HPLC purity testing assess different material characteristics.

Batch-specific analytical documentation supports laboratory quality assessment and material traceability.

For additional information about research material classifications and documentation, review the Research Use Only Peptides Guide.

Storage and Handling

Keep the KPV vial sealed until required for an authorized laboratory workflow.

Store the lyophilized research material in a cold, dry environment protected from moisture, excessive heat and direct light.

Follow the storage temperature and handling recommendations provided on the product label and applicable batch-specific documentation.

Appropriate storage conditions help maintain the integrity of synthetic peptides during laboratory handling and analytical investigations.

Avoid using material from containers with damaged packaging, broken seals or uncertain identification.

Reconstitution Solution is available separately for suitable laboratory applications, subject to compatibility with the intended research workflow.

Researchers seeking general information about handling lyophilized peptides can review the educational guide on how peptide reconstitution works.

Related Research Materials

Laboratories investigating short regulatory peptides, cellular signalling and molecular interactions may also examine other research compounds associated with these areas of study.

• KLOW Blend – A four-component research formulation containing GHK-Cu 50mg, BPC-157 10mg, TB-500 10mg and KPV 10mg, providing 80mg of total lyophilized material.
• BPC-157 – A synthetic 15-amino-acid peptide investigated in non-clinical laboratory models involving molecular interactions, cellular signalling and peptide stability.
• GHK-Cu – A copper-binding tripeptide complex studied in peptide-metal coordination, molecular characterization and extracellular matrix-associated research.
• GLOW Blend – A three-component formulation containing GHK-Cu, BPC-157 and TB-500. Unlike KLOW Blend, this formulation does not contain KPV.

These compounds have distinct molecular structures and research applications.

KPV is a short tripeptide derived from the alpha-MSH sequence, while GHK-Cu is a copper-binding peptide complex and BPC-157 is a longer synthetic peptide.

Researchers can explore additional compounds through the PCH Peptides research catalog.

Frequently Asked Questions

What is KPV peptide?

KPV is a synthetic tripeptide composed of lysine, proline and valine.

It corresponds to the C-terminal three-amino-acid sequence of alpha-melanocyte-stimulating hormone (alpha-MSH).

PCH Peptides supplies KPV as a lyophilized research material for qualified laboratory investigations.

What is KPV used for in research?

KPV is investigated in laboratory models involving inflammatory signalling, short-peptide chemistry, molecular characterization and peptide transport.

Researchers have also examined its interactions with NF-κB-related signalling pathways in controlled experimental settings.

These research applications do not establish therapeutic effectiveness or safety for human use.

What is the amino acid sequence of KPV?

KPV contains three amino acids arranged in the sequence Lys-Pro-Val.

The sequence consists of lysine, proline and valine and corresponds to residues 11–13 of alpha-MSH.

What is the molecular weight of KPV?

KPV has an approximate molecular weight of 342.4 g/mol and a molecular formula of C16H30N4O4.

These specifications refer to the unmodified tripeptide.

Researchers should verify the molecular identity and any salt-form specifications against the applicable batch documentation.

How is KPV related to alpha-MSH?

KPV corresponds to the final three amino acid residues of alpha-melanocyte-stimulating hormone.

Alpha-MSH is a 13-amino-acid peptide, while KPV contains only its C-terminal Lys-Pro-Val sequence.

Researchers investigate the shorter fragment to characterize peptide structure and related molecular interactions.

What size does KPV come in?

PCH Peptides supplies KPV as a 10mg lyophilized research material in a single vial.

The product is intended exclusively for laboratory, academic and institutional research.

Is KPV available in a blend?

Yes. KPV is one of four components in KLOW Blend.

The blend contains GHK-Cu 50mg, BPC-157 10mg, TB-500 10mg and KPV 10mg, providing 80mg total research material.

KPV is also available as an individual 10mg vial for laboratories requiring separate compound characterization.

What is the difference between KPV and GHK-Cu?

Both KPV and GHK-Cu contain three amino acid residues, but they have different molecular structures.

KPV consists of lysine, proline and valine, whereas GHK-Cu is a copper-binding complex formed from glycine, histidine and lysine.

Researchers investigate these compounds in different biochemical models involving peptide signalling, molecular interactions and metal-peptide coordination.

Is KPV batch tested?

The PCH Peptides COA Library lists one Certificate of Analysis and one endotoxin report for KPV.

Researchers should review the applicable batch documentation to confirm compound identity, purity and analytical findings.

Available documentation can be accessed through the COA Library.

How should KPV be stored?

KPV should remain sealed and protected from moisture, excessive heat and direct light.

Follow the storage temperature and handling recommendations printed on the product label and any applicable batch-specific documentation.

Appropriate storage helps maintain the integrity of lyophilized research materials.

Is KPV intended for human or animal use?

No. KPV is supplied strictly for laboratory, academic and institutional research.

It is not intended for human or animal consumption, injection, therapeutic applications, diagnosis or veterinary use.

For more information about research material restrictions, review the Research Use Only Peptides Guide.

Do you provide dosage instructions for KPV?

No. PCH Peptides does not provide dosage, administration or usage protocols. KPV is supplied exclusively for qualified research use only.